Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Profile photo

Tine Willum Hansen

Primære forskningsområder

Kardiovaskulær billeddiagnostik og mikrocirkulation i diabetes:

Kliniske studier om biomarkører og screeningmetoder til at identificere personer med øget risiko for hjertekarsygdom.

Herunder kardiovaskulær billeddiagnostik og undersøgelser af mikrocirkulation.

Ansættelse

Afdeling for Klinisk Fysiologi og Nuklearmedicin

Rigshospitalet

1 jan. 201031 dec. 2012

Publikationer

Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

Heinrich, N. S., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S., Jeppesen, J. L., Persson, F., Hansen, T. W., Goetze, J. P. & Rossing, P., 2022, I: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 1, s. 100-107

Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [123 I]MIBG heart scintigraphy

Lindberg, L., Brinth, L. S., Bergmann, M. L., Kristensen, B., Hansen, T. W., Hasbak, P., Thomsen, J. F., Eldrup, E. & Jensen, L. T., 31 dec. 2021, (E-pub ahead of print) I: Clinical Physiology and Functional Imaging.

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls

Laursen, J. C., Rasmussen, I. K. B., Zobel, E. H., Hasbak, P., von Scholten, B. J., Holmvang, L., Ripa, R. S., Hansen, C. S., Frimodt-Moeller, M., Kjaer, A., Rossing, P. & Hansen, T. W., 13 dec. 2021, I: Frontiers in Endocrinology. 12, s. 780679 780679.

Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trial

Rasmussen, I. K. B., Zobel, E. H., Ripa, R. S., von Scholten, B. J., Curovic, V. R., Jensen, J. K., Kjaer, A., Hansen, T. W. & Rossing, P., dec. 2021, I: Diabetes, Obesity and Metabolism. 23, 12, s. 2651-2659 9 s.

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [Cu-64]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial: Results from the LIRAFLAME Trial

Jensen, J. K., Zobel, E. H., von Scholten, B. J., Rotbain Curovic, V., Hansen, T. W., Rossing, P., Kjaer, A. & Ripa, R. S., 30 nov. 2021, I: Frontiers in Endocrinology. 12, s. 790405 790405.

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, P., 21 okt. 2021, (E-pub ahead of print) I: Diabetes, Obesity and Metabolism.

Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

Zobel, E. H., Ripa, R. S., von Scholten, B. J., Rotbain Curovic, V., Kjaer, A., Hansen, T. W., Rossing, P. & Størling, J., 17 sep. 2021, I: Scientific Reports. 11, 1, s. 18522 18522.

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

Zobel, E. H., Wretlind, A., Ripa, R. S., Rotbain Curovic, V., von Scholten, B. J., Suvitaival, T., Hansen, T. W., Kjær, A., Legido-Quigley, C. & Rossing, P., sep. 2021, I: BMJ open diabetes research & care. 9, 1, e002395.

Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATE

Zobel, E. H., Ripa, R. S., von Scholten, B. J., Curovic, V. R., Diaz, L. J., Hansen, T. W., Rossing, P. & Kjaer, A., 8 aug. 2021, I: Diagnostics. 11, 8, 1431.

Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial: A Randomized, Double-Blind, Placebo-Controlled Trial

Ripa, R. S., Zobel, E. H., von Scholten, B. J., Jensen, J. K., Binderup, T., Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, P. & Kjaer, A., jul. 2021, I: Circulation. Cardiovascular Imaging. 14, 7, s. e012174 e012174.

Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls

Rasmussen, I. K. B., Hasbak, P., von Scholten, B. J., Laursen, J. C., Zobel, E. H., Jorge Diaz, L., Holmvang, L., Ripa, R. S., Rossing, P., Kjaer, A. & Hansen, T. W., jun. 2021, I: Diabetic Medicine. 38, 6, s. e14517

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

Winther, S. A., Øllgaard, J. C., Hansen, T. W., von Scholten, B. J., Reinhard, H., Ahluwalia, T. S., Wang, Z., Gæde, P., Parving, H-H., Hazen, S., Pedersen, O. & Rossing, P., mar. 2021, I: PLoS One. 16, 3, s. e0244402 e0244402.

Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Tofte, N., Theilade, S., Winther, S. A., Birkelund, S., Goetze, J. P., Hansen, T. W. & Rossing, P., feb. 2021, I: Diabetes Care. 44, 2, s. 595-603 9 s.

Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

Winther, S. A., Henriksen, P., Vogt, J. K., Hansen, T. H., Ahonen, L., Suvitaival, T., Hein Zobel, E., Frimodt-Møller, M., Hansen, T. W., Hansen, T., Parving, H-H., Legido-Quigley, C., Rossing, P. & Pedersen, O., dec. 2020, I: Diabetologia. 63, 12, s. 2713-2724 12 s.

Changes in cardiac microvascular function in persons with type 2 diabetes in relation to kidney function

Rasmussen, I. K. B., Hasbak, P., von Scholten, B. J., Laursen, J. C., Zobel, E. H., Holmvang, L., Ripa, R. S., Rossing, P., Kjær, A. & Hansen, T. W., 22 okt. 2020.

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

Jensen, J., Schou, M., Kistorp, C., Faber, J., Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, P., Vilsbøll, T. & Jørgensen, P. G., 16 okt. 2020, I: Cardiovascular Diabetology. 19, 1, s. 180 180.

Non invasive assessment of changes in cardiac microvascular function in persons with type 2 diabetes

Rasmussen, I. K. B., Hasbak, P., von Scholten, B. J., Laursen, J. C., Zobel, E. H., Holmvang, L., Ripa, R. S., Rossing, P., Kjær, A. & Hansen, T. W., 21 sep. 2020.

High Sympathetic Activity in Raynaud's Disease

Lindberg, L., Kristensen, B., Hansen, T. W., Hasbak, P., Thomsen, J. F., Eldrup, E. & Jensen, L. T., sep. 2020, I: European Journal of Nuclear Medicine and Molecular Imaging. 47, SUPPL 1, s. S145-S146

Major decreases in the lipidome following liraglutide treatment: 21-25 September 2020.

Wretlind, A., Zobel, E. H., Ripa, R. S., Von Scholten, B. J., Suvitaival, T., Hansen, T. W., Vestergaard, H., Kjær, A., Legido-Quigley, C. & Rossing, P., 25 aug. 2020, I: Diabetologia. 63, Suppl 1, s. S252 525.

Profiling of gut microbiota and plasma metabolites in persons with type 1 diabetes and kidney disease

Henriksen, P., Winther, S. A., Vogt, J. K., Hansen, T. H., Ahonen, L. L., Suvitaival, T., Frimodt-Møller, M., Hansen, T. W., Hansen, T., Parving, H-H. D., Legido-Quigley, C., Rossing, P. & Pedersen, O., 25 aug. 2020, I: Diabetologia. 63, Suppl 1, s. S384 795.

Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuria

Heinrich, N. S., von Scholten, B. J., Reinhard, H., Persson, F., Ahluwalia, T. S., Hansen, T. W., Parving, H-H., Jacobsen, P. K. & Rossing, P., jul. 2020, I: Journal of Diabetes and its Complications. 34, 7, s. 107593 107593.

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

Zobel, E. H., Christensen, R. H., Winther, S. A., Hasbak, P., Hansen, C. S., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 10 feb. 2020, I: Cardiovascular Diabetology. 19, 1, 16.

Liraglutide and vascular inflammation in type 2 diabetes as assessed by FDG-PET/CT: The LiraFlame study

Ripa, R. S., Zobel, E. H., Von Scholten, B. J., Diaz, L. J., Jensen, J. K., Curovic, V. R., Hansen, T. W., Rossing, P. & Kjær, A., 2020.

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Winther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H-H., Hansen, T. W., Hazen, S. L., Pedersen, O. & Rossing, P., aug. 2019, I: Diabetes Care. 42, 8, s. 1512-1520 9 s.

Myocardial flow reserve assessed by cardiac 82Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetes

Zobel, E. H., Winther, S. A., Hasbak, P., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 1 jul. 2019, I: European heart journal cardiovascular Imaging. 20, 7, s. 796-803 8 s., jey174.

Cardiac Autonomic Function is Associated With Myocardial Flow Reserve in Type 1 Diabetes

Zobel, E. H., Hasbak, P., Winther, S. A., Stevns, C., Fleischer, J., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 1 jun. 2019, I: Diabetes. 68, 6, s. 1277-1286 10 s.

The utility of plasma concentration of Trimethylamine-N-Oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes

Winther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H-H. D., Hansen, T. W., Hazen, S. L., Pedersen, O. & Rossing, P., 24 maj 2019.

Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes

Jensen, J., Schou, M., Kistorp, C., Faber, J., Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, P., Vilsbøll, T. & Jørgensen, P. G., mar. 2019, I: Diabetes, Obesity and Metabolism. 21, 3, s. 736-740 5 s.

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

Rotbain Curovic, V., Hansen, T. W., Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Persson, F., Parving, H-H. & Rossing, P., nov. 2018, I: Acta Diabetologica. 55, 11, s. 1143-1150 7 s.

Myocardial Flow Reserve Assessed by Cardiac 82Rb PET/CT Is Associated with Albumin Excretion in Patients with Type 1 Diabetes

Zobel, E. H., Winther, S. A., Von Scholten, B. J., Holmvang, L., Kjær, A., Rossing, P. & Hansen, T. W., 26 okt. 2018, I: Journal of the American Society of Nephrology. FR-PO429.

Collagen Type III Degradation Is Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Genovesa, F., Hansen, T. W., Rasmussen, D. G. K., Nielsen, S. H., Reinhard, H., Von Scholten, B. J., Persson, F., Jacobsen, P. K., Parving, H-H. D., Karsdal, M. A. & Rossing, P., okt. 2018, I: Diabetologia. 61, s. S492-S492 1 s., 1001.

Myocardial flow reserve assessed by Cardiac 82Rb PET/CT is associated with albumin excretion in patients with type 1 diabetes

Hansen, T. W., Zobel, E. H., Hasbak, P., Winther, S. A., Kjær, A., Holmvang, L. & Rossing, P., 20 sep. 2018, I: Journal of Hypertension. 36, e suppl 3, s. S531-S531 1 s., A3993.

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

Rasmussen, D. G. K., Hansen, T. W., von Scholten, B. J., Nielsen, S. H., Reinhard, H., Parving, H-H., Tepel, M., Karsdal, M. A., Jacobsen, P. K., Genovese, F. & Rossing, P., jul. 2018, I: Diabetes Care. 41, 7, s. 1493-1500 7 s.

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria.

Hansen, T. W., Rasmussen, D., Von Scholten, B. J., Nielsen, S., Reinhard, H., Parving, H-H. D., Tepel, M., Karsdal, M., Genovese, F. & Rossing, P., 17 maj 2018.

COLLAGEN TYPE III DEGRADATION IS ASSOCIATED WITH DETERIORATION OF KIDNEY FUNCTION IN PATIENTS WITH TYPE 2 DIABETES WITH MICROALBUMINURIA.

Frimodt-Moller, M., Genovese, F., Hansen, T., Rasmussen, D., Nielsen, S., Reinhard, H., von Scholten, B. J., Persson, F., Jacobsen, P., Parving, H-H., Karsdal, M. & Rossing, P., 1 maj 2018, I: Nephrology Dialysis Transplantation. 33, 1, 1 s., SP418.

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Hansen, T. W., Persson, F. I., Parving, H-H. & Rossing, P., 2018, I: P L o S One. 13, 4, s. e0196634

Symmetric and Asymmetric Dimethylarginine as Risk Markers of Cardiovascular Disease, All-Cause Mortality, and Deterioration in Kidney Function in Patients with Type 2 Diabetes and Microalbuminuria

Persson, F., Zobel, E. H., von Scholten, B. J., Hansen, T. W., Parving, H-H. D. & Rossing, P., 4 nov. 2017. 1 s.

A Novel Marker of Collagen Type VI Formation Is Prognostic for Cardiovascular Disease, All-Cause Mortality, and Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Guldager, D. K. R., Hansen, T. W., Nielsen, S. H., Reinhard, H., Parving, H-H. D., Karsdal, M. A., Genovese, F. & Rossing, P., 3 nov. 2017. 1 s.

Collagen Type III Degradation Is Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Genovese, F., Hansen, T. W., Guldager, D. K. R., Nielsen, S. H., Reinhard, H., Parving, H-H. D., Karsdal, M. A. & Rossing, P., 3 nov. 2017. 1 s.

GDF-15 and FGF-23 Are Associated with Mortality in Type 2 Diabetic Patients with Microalbuminuria

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 3 nov. 2017. 1 s.

Is Urinary KIM-1 a Predictor of EGFR Decline, Incident Cardiovascular Disease, and All Cause Mortality?

Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 3 nov. 2017. 1 s.

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy

Galsgaard, J., Persson, F., Hansen, T. W., Jorsal, A., Tarnow, L., Parving, H-H. & Rossing, P., nov. 2017, I: Kidney International. 92, 5, s. 1242-1248 6 s.

Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria

Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Hansen, T. W., Parving, H. H., Jacobsen, P. K. & Rossing, P., okt. 2017, I: Diabetologia. 60, 10, s. 1883-1891 8 s.

GDF-15 and FGF-23 are associated with mortality in type 2 diabetic patients with microalbuminuria

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 12 sep. 2017. 1 s.

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Teerlink, T., Hansen, T. W., Parving, H-H., Jacobsen, P. K. & Rossing, P., 11 jul. 2017, I: Cardiovascular Diabetology. 16, 1, s. e88

Effect of large weight reductions on measured and estimated kidney function

von Scholten, B. J., Persson, F., Svane, M. S., Hansen, T. W., Madsbad, S. & Rossing, P., 1 feb. 2017, I: BMC Nephrology. 18, 1, s. 52

The effect of liraglutide on renal function: A randomized clinical trial

von Scholten, B. J., Persson, F., Rosenlund, S., Hovind, P., Faber, J., Hansen, T. W. & Rossing, P., feb. 2017, I: Diabetes, Obesity and Metabolism. 19, 2, s. 239-247

Cardiac Autonomic Function Is Associated With the Coronary Microcirculatory Function in Patients With Type 2 Diabetes

von Scholten, B. J., Hansen, C. S., Hasbak, P., Kjaer, A., Rossing, P. & Hansen, T. W., okt. 2016, I: Diabetes. 65, 10, s. 3129-38 10 s.

Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria

von Scholten, B. J., Reinhard, H., Hansen, T. W., Oellgaard, J. C., Parving, H-H., Jacobsen, P. K. & Rossing, P., jul. 2016, I: Diabetologia. 59, 7, s. 1549-57 9 s.

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R⁺ T cells

von Scholten, B. J., Rosendahl, A., Hasbak, P., Bergholdt, R., Kjaer, A., Rossing, P. & Hansen, T. W., 19 apr. 2016, I: Cardiovascular Diabetology. 15, s. 67

Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes

von Scholten, B. J., Hasbak, P., Christensen, T. E., Ghotbi, A. A., Kjaer, A., Rossing, P. & Hansen, T. W., feb. 2016, I: Diabetologia. 59, 2, s. 371-8 8 s.

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes

Zobel, E. H., von Scholten, B. J., Lajer, M., Jorsal, A., Tarnow, L., Rasmussen, L. M., Holstein, P., Parving, H-H., Hansen, T. W. & Rossing, P., 2016, I: Journal of Diabetes and its Complications. 30, 8, s. 1603-08

Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria

von Scholten, B. J., Reinhard, H., Hansen, T. W., Schalkwijk, C. G., Stehouwer, C., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2016, I: Journal of Diabetes and its Complications. 30, 2, s. 248-55

Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes

von Scholten, B. J., Hansen, T. W., Goetze, J. P., Persson, F. & Rossing, P., jul. 2015, I: Journal of Diabetes and its Complications. 29, 5, s. 670-4 5 s.

Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes

Theilade, S., Hansen, T. W., Goetze, J. P. & Rossing, P., jun. 2015, I: American Journal of Hypertension. 28, 6, s. 772-9 8 s.

Prognosis in relation to blood pressure variability: con side of the argument

Asayama, K., Wei, F-F., Hara, A., Hansen, T. W., Li, Y. & Staessen, J. A., jun. 2015, I: Hypertension. 65, 6, s. 1170-9; discussion 1179

Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia-the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

Theilade, S., Claggett, B., Hansen, T. W., Skali, H., Lewis, E. F., Solomon, S. D., Parving, H-H., Pfeffer, M., McMurray, J. J. & Rossing, P., 26 mar. 2015, I: Journal of Hypertension. 30, s. 46-52

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

Theilade, S., Lyngbaek, S., Hansen, T. W., Eugen-Olsen, J., Fenger, M., Rossing, P. & Jeppesen, J. L., mar. 2015, I: Journal of Internal Medicine. 277, 3, s. 362-71 10 s.

Improved prognosis of diabetic nephropathy in type 1 diabetes

Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H-H., Hovind, P., Hansen, T. W. & Rossing, P., feb. 2015, I: Kidney International. 87, 2, s. 417-26 10 s.

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes

von Scholten, B. J., Reinhard, H., Hansen, T. W., Lindhardt, M., Petersen, C. L., Wiinberg, N., Hansen, P. R., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2015, I: Cardiovascular Diabetology. 14, s. 59

Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors

Andrésdóttir, G., Jensen, M., Carstensen, B., Parving, H-H., Rossing, K., Hansen, T. W. & Rossing, P., jun. 2014, I: Diabetes Care. 37, 6, s. 1660-7 8 s.

Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification

Li, Y., Thijs, L., Boggia, J., Asayama, K., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L., Sandoya, E., Kawecka-Jaszcz, K., Filipovsky, J., Imai, Y., Ibsen, H., O'Brien, E., Wang, J., Staessen, J. A. & International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators*, maj 2014, I: Hypertension. 63, 5, s. 925-33 9 s.

Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects

Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C-H., Cruickshank, J. K., Hwang, S-J., Lakatta, E. G., Laurent, S., Maldonado, J., Mitchell, G. F., Najjar, S. S., Newman, A. B., Ohishi, M., Pannier, B., Pereira, T., Vasan, R. S., Shokawa, T., Sutton-Tyrell, K., Verbeke, F., Wang, K-L., Webb, D. J., Hansen, T. W., Zoungas, S., McEniery, C. M., Cockcroft, J. R. & Wilkinson, I., feb. 2014, I: Journal of the American College of Cardiology. 63, 7, s. 636-46 11 s.

Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations

Gu, Y-M., Thijs, L., Li, Y., Asayama, K., Boggia, J., Hansen, T. W., Liu, Y-P., Ohkubo, T., Björklund-Bodegård, K., Jeppesen, J., Dolan, E., Torp-Pedersen, C., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L., Sandoya, E., Kawecka-Jaszcz, K., Imai, Y., Mena, L. J., Wang, J., O'Brien, E., Verhamme, P., Filipovsky, J., Maestre, G. E., Staessen, J. A. & International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators, feb. 2014, I: Hypertension. 63, 2, s. 229-37 9 s.

Response to Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations and response to Is masked hypertension related to diabetes mellitus?

Franklin, S. S., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Liu, Y., Asayama, K., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Sandoya, E., Kawecka-Jaszcz, K., Filipovský, J., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators, okt. 2013, I: Hypertension. 62, 4, s. e23-5

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

Lyngbæk, S., Marott, J. L., Sehestedt, T., Hansen, T. W., Olsen, M. H., Andersen, O., Linneberg, A., Haugaard, S. B., Eugen-Olsen, J., Hansen, P. R. & Jeppesen, J., 10 sep. 2013, I: International Journal of Cardiology. 167, 6, s. 2904-11 8 s.

CRP and suPAR are differently related to anthropometry and subclinical organ damage

Lyngbæk, S., Sehestedt, T., Marott, J. L., Hansen, T. W., Olsen, M. H., Andersen, O., Linneberg, A., Madsbad, S., Haugaard, S. B., Eugen-Olsen, J. & Jeppesen, J., 10 aug. 2013, I: International Journal of Cardiology. 167, 3, s. 781-85 5 s.

Double product reflects the predictive power of systolic pressure in the general population: evidence from 9,937 participants

Schutte, R., Thijs, L., Asayama, K., Boggia, J., Li, Y., Hansen, T. W., Liu, Y-P., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Sandoya, E., Kawecka-Jaszcz, K., Filipovsky, J., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators, maj 2013, I: American Journal of Hypertension. 26, 5, s. 665-72 8 s.

Masked hypertension in diabetes mellitus: treatment implications for clinical practice

Franklin, S. S., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Liu, Y., Asayama, K., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Sandoya, E., Kawecka-Jaszcz, K., Filipovsky, J., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & International Database on Ambulatory blood pressure in Relation to Cardiovascular Outcomes Investigators, maj 2013, I: Hypertension. 61, 5, s. 964-71 8 s.

Risk Stratification by 24-Hour Ambulatory Blood Pressure and Estimated Glomerular Filtration Rate in 5322 Subjects From 11 Populations

Boggia, J., Thijs, L., Li, Y., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Schwedt, E., Sandoya, E., Kawecka-Jaszcz, K., Filipovsky, J., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators, 2013, I: Hypertension. 61, 1, s. 18-26 9 s.

Blodtryk skal ikke kun måles om dagen

Jørgensen, S. M. & Hansen, T. W., 1 jan. 2012, I: Ugeskrift for Laeger. 174, 3, s. 110-112 3 s.

Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?

Sehestedt, T., Jeppesen, J., Hansen, T. W., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Olsen, M. H., 2012, I: Journal of Hypertension. 30, 3, s. 513-521 9 s.

Fibrillin-1 genotype and risk of prevalent hypertension: A study in two independent populations

Jeppesen, J., Berg, N. D., Torp-Pedersen, C., Hansen, T. W., Linneberg, A. & Fenger, M., 2012, I: Blood Pressure. 21, 5, s. 273-280

Genetic Variation in the Natriuretic Peptide System, Circulating Natriuretic Peptide Levels, and Blood Pressure: An Ambulatory Blood Pressure Study

Jeppesen, J. L., Nielsen, S. J., Torp-Pedersen, C., Hansen, T. W., Olsen, M. H., Berg, N. D., Linneberg, A., Madsbad, S. & Fenger, M., 2012, I: American Journal of Hypertension. 25, 10, s. 1095-1100

Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population

Franklin, S. S., Thijs, L., Hansen, T. W., Li, Y., Boggia, J., Kikuya, M., Björklund-Bodegård, K., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Sandoya, E., Kawecka-Jaszcz, K., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, 2012, I: Hypertension. 59, 3, s. 564-71 8 s.

Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts

Sehestedt, T., Jeppesen, J., Hansen, T. W., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Olsen, M. H., 2012, I: Journal of Hypertension. 30, 10, s. 1928-36 9 s.

Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO)

Stolarz-Skrzypek, K., Thijs, L., Li, Y., Hansen, T. W., Boggia, J., Kuznetsova, T., Kikuya, M., Maestre, G., Mena, L., Kawecka-Jaszcz, K. & Staessen, J. A., 23 dec. 2011, I: Acta Cardiologica. 66, 6, s. 701-706 6 s.

Response to referral of women to ambulatory blood pressure monitoring

Boggia, J., Hansen, T. W., Li, Y., Kikuya, M., Thijs, L. & Staessen, J. A., 1 jun. 2011, I: Hypertension. 57, 6

Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

Sehestedt, T., Lyngbæk, S., Eugen-Olsen, J., Jeppesen, J., Andersen, O., Hansen, T. W., Linneberg, A., Jørgensen, T., Haugaard, S. B. & Olsen, M. H., 1 maj 2011, I: Atherosclerosis. 216, 1, s. 237-43 7 s.

Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women

Boggia, J., Thijs, L., Hansen, T. W., Li, Y., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Jeppesen, J. L., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Olszanecka, A., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Maestre, G., Sandoya, E., Kawecka-Jaszcz, K., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., Staessen, J. A. & International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes Investigators, 1 mar. 2011, I: Hypertension. 57, 3, s. 397-405 9 s.

Are blood pressure and diabetes additive or synergistic risk factors? outcome in 8494 subjects randomly recruited from 10 populations

Sehestedt, T., Hansen, T. W., Li, Y., Richart, T., Boggia, J., Kikuya, M., Thijs, L., Stolarz-Skrzypek, K., Casiglia, E., Tikhonoff, V., Malyutina, S., Nikitin, Y., Björklund-Bodegård, K., Kuznetsova, T., Ohkubo, T., Lind, L. S., Torp-Pedersen, C., Jeppesen, J. L., Ibsen, H., Imai, Y., Wang, J., Sandoya, E., Kawecka-Jaszcz, K. & Staessen, J. A., 10 feb. 2011, I: Hypertension research : official journal of the Japanese Society of Hypertension. 34, s. 714-721

Predictive role of the nighttime blood pressure

Hansen, T. W., Li, Y., Boggia, J., Thijs, L., Richart, T. & Staessen, J. A., 2011, I: Hypertension. 57, 1, s. 3-10 8 s.

Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study

Nielsen, S. J., Jeppesen, J. L., Torp-Pedersen, C., Hansen, T. W., Linneberg, A. & Fenger, M., 1 dec. 2010, I: American Journal of Hypertension. 23, 12, s. 1306-11 6 s.

Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'

Hansen, T. W. & Reference Values for Arterial Stiffness' Collaboration, 1 okt. 2010, I: European Heart Journal. 31, 19, s. 2338-50 13 s.

Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations

Fan, H-Q., Li, Y., Thijs, L., Hansen, T. W., Boggia, J., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L. S., Sandoya, E., Kawecka-Jaszcz, K., Imai, Y., Ibsen, H., O'Brien, E., Wang, J., Staessen, J. A. & International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators, 1 okt. 2010, I: Journal of Hypertension. 28, 10, s. 2036-45 10 s.

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

Eugen-Olsen, J., Andersen, O., Linneberg, A., Ladelund, S., Hansen, T. W., Langkilde, A., Petersen, J., Pielak, T., Møller, L. N., Jeppesen, J., Lyngbæk, S., Fenger, M., Olsen, M. H., Hildebrandt, P. R., Borch-Johnsen, K., Jørgensen, T. & Haugaard, S. B., 1 sep. 2010, I: Journal of Internal Medicine. 268, 3, s. 296-308 13 s.

Blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome

Stolarz-Skrzypek, K., Thijs, L., Richart, T., Li, Y., Hansen, T. W., Boggia, J., Kuznetsova, T., Kikuya, M., Kawecka-Jaszcz, K. & Staessen, J. A., 1 aug. 2010, I: Hypertension Research. 33, 8, s. 757-66 10 s.

From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickering's legacy

Stolarz-Skrzypek, K., Thijs, L., Wizner, B., Richart, T., Ogedegbe, G., Li, Y., Hansen, T. W., Boggia, J., Kikuya, M., Kuznetsova, T., Wang, J., Lurbe, E., Imai, Y., Kawecka-Jaszcz, K. & Staessen, J. A., 1 apr. 2010, I: Blood Pressure Monitoring. 15, 2, s. 72-81 10 s.

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

Sehestedt, T., Jeppesen, J. L., Hansen, T. W., Wachtell, K., Ibsen, H., Torp-Pedersen, C., Hildebrandt, P. & Olsen, M. H., 1 apr. 2010, I: European Heart Journal. 31, 7, s. 883-91 9 s.

Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?

Olsen, M. H., Sehestedt, T., Lyngbaek, S., Hansen, T. W., Rasmussen, S., Wachtell, K., Torp-Pedersen, C., Hildebrandt, P. R. & Ibsen, H., 1 jan. 2010, I: Current Vascular Pharmacology. 8, 1, s. 134-9 6 s.

The Reference Values for Arterial Stifness? Collaboration. Determinants of Pulse wave velocity in healthy people amd im the presence of cardiovascular rsik factors: "establishing normal and reference values"

Mattace-Raso, F. U., Hofman, A., Verwoert, G. C., Wittemana, J. C., Wilkinson, I., Cockcroft, J., McEniery, C., Yasmin, Laurent, S., Boutouyrie, P., Bozec, E., Hansen, T. W., Torp-Pedersen, C. T., Ibsen, H., Jeppesen, J., Vermeersch, S. J., Rietzschel, E., De Buyzere, M., Gilbert, T. C., Van Bortel, L., Segers, P., Vlachopoulos, C., Aznouridis, C., Stefanadis, C., Benetos, A., Labat, C., Lacolley, P., Stehouwer, C. D., Nijpels, G., Dekker, J. M., Ferreira, I., Twisk, J. W., Czernichow, S., Galan, P., Hercberg, S., Pannier, B., Guérin, A., London, G., Cruickshank, J. K., Anderson, S. G., Paini, A., Agabiti Rosei, E., Muiesan, M. L., Salvetti, M., Filipovsky, J., Seidlerova, J. & Dolejsova, M., 2010, I: Eur.Heart J.. 31, s. 2338-2350

Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population

Sehestedt, T., Jeppesen, J., Hansen, T. W., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Olsen, M. H., 2009, I: Journal of Hypertension. 27, 12, s. 2351-7 6 s.

Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

Sehestedt, T., Jeppesen, J., Hansen, T. W., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Olsen, M. H., 2009, I: Journal of Hypertension. 27, 6, s. 1165-71 6 s.

New risk markers may change the HeartScore risk classification significantly in one-fifth of the population

Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Hildebrandt, P. R., 2008, I: Journal of Human Hypertension. 23, 2, s. 105-112 7 s.

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population

Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. & Hildebrandt, P. R., 1 jun. 2007, I: European Heart Journal. 28, 11, s. 1374-1381 8 s.

High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors

Olsen, M. H., Christensen, M. K., Hansen, T. W., Gustafsson, F., Rasmussen, S., Wachtell, K., Borch-Johnsen, K., Ibsen, H., Jørgensen, T. & Hildebrandt, P., 2006, I: Journal of Hypertension. 24, 4, s. 655-61 7 s.

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome

Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Borch-Johnsen, K., Ibsen, H., Jørgensen, T. & Hildebrandt, P., 1 okt. 2005, I: Hypertension. 46, 4, s. 660-666 7 s.

Aktiviteter

Myocardial Flow Reserve Assessed by Cardiac 82Rb PET/CT Is Associated with Albumin Excretion in Patients with Type 1 Diabetes

Emilie Hein Zobel (Foredragsholder), Signe Abitz Winther (Andet), Bernt Johan von Scholten (Andet), Lene Holmvang (Andet), Andreas Kjær (Andet), Peter Rossing (Andet) & Tine Willum Hansen (Andet)

26 okt. 2018

ID: 38414